Skip to main content
Clinical Trials/NCT02619188
NCT02619188UnknownNot Applicable

Pregnancy Unique Questionnaire of Emesis (PUQE) Methode Evaluation; Relation Between Rate of Nausea/Vomiting in Pregnancy (PUQE-score), Self-reported Nutritional Intake and Biochemical Nutritional Markers

Haukeland University Hospital1 site in 1 country60 target enrollmentStarted: September 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Prealbumin in normal pregnancy

Study Overview

Brief Summary

This study evaluate the rate of nausea and nutritional status in patients with hyperemesis gravidarum (severe nausea and vomiting in pregnancy) and healthy pregnant women using a questionnaire (PUQE-score), self-reported food/drink intake form and blood test. The Investigators aim for developing normal range of prealbumin measurements (reference values) during first trimester of pregnancy.

Detailed Description

Women affected with hyperemesis gravidarum are at severe nutritional risk. Reference values for biochemical parameters evaluating nutritional status during early pregnancy needs to be determined.

The investigators will compare clinical nutritional parameters (weight gain/weight loss) with rate of nausea (PUQE-questionnaire), self-reported nutritional intake form and biochemical measurements (prealbumin) in women admitted to hospital with hyperemesis gravidarum and healthy pregnant women.

For hyperemesis patients measurements will be repeated at discharge.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Pregnant women < 16 weeks of gestation
  • Admitted to hospital for hyperemesis gravidarum (HG group) with nausea and vomiting in pregnancy with at least two of following criteria; weight loss, dehydration, fluid-/electrolyte disturbances, ketonuria

Exclusion Criteria

  • Non-viable pregnancy diagnosed at time of inclusion
  • Unable to understand Norwegian
  • PUQE-score >= 13 (control group)
  • Nausea an vomiting in pregnancy caused by other conditions than Hyperemesis gravidarum

Outcomes

Primary Outcomes

Prealbumin in normal pregnancy

Time Frame: Within 24h at inclusion

Serum Prealbumin measured during first trimester of pregnancy

Secondary Outcomes

  • Change in Prealbumin(Patients will be followed until discharge from hospital, a mean of 5 days, and blood sampling repeated at discharge)
  • Prealbumin related to nutritional parameters(Within 24h at inclusion)
  • Prealbumin in Hyperemesis gravidarum(Within 2h from admission to hospital)

Investigators

Sponsor
Haukeland University Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials